The Frequency of PAI, aer and traT Genes in Escherichia coli Commensal and Urinary Pathogenic E. coli Isolates in Shahrekord and the Relationship Between the Two Groups by Multiplex PCR by Rezaei, Mohamad Hossein et al.
Jundishapur J Microbiol. 2020 June; 13(6):e98683.
Published online 2020 July 5.
doi: 10.5812/jjm.98683.
Research Article
The Frequency of PAI, aer and traT Genes in Escherichia coli
Commensal and Urinary Pathogenic E. coli Isolates in Shahrekord and
the Relationship Between the Two Groups by Multiplex PCR
Mohamad Hossein Rezaei 1, Farshad Kakian 2, Abolfazl Gholipour 3 and Behnam Zamanzad 3, *
1Cellular and Molecular Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
2Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
3Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran
*Corresponding author: Department of Microbiology and Immunology, Cellular and Molecular Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Tel: +98-3833346732, Fax: +98-383334911, Email: bzamanzad@yahoo.com
Received 2019 October 21; Revised 2020 May 05; Accepted 2020 May 14.
Abstract
Background: Nosocomial infections are acquired during hospital treatment or in a hospital environment. One such infecting agent
is uropathogenic Escherichia coli and many virulence genes enable it to become pathogenic, thereby causing damage to the host.
Objectives: This study aimed to identify aer, traT, and PAI genes in E. coli isolates collected from fecal and urinary tract infection (UTI)
specimens and determine the relationship between them in both populations studied in a center in Iran by multiplex polymerase
chain reaction (PCR) assay.
Methods: Seventy-five isolates of E. coli from the urine of inpatients and 75 isolates from commensal fecal without UTI and diar-
rhea were collected. The E. coli bacteria were detected and isolated, using biochemical techniques and supplementary tests in the
Microbiology Laboratory of Shahrekord University of Medical Sciences. Antibiotic susceptibility pattern for 14 antibiotics was done
utilizing the disc diffusion method. The existence of aer, traT, and PAI virulence genes among all isolates was investigated by multi-
plex PCR.
Results: Among the urinary pathogenic E. coli isolates, the highest antibiotic resistance was observed in cefazolin, ampicillin, and
cotrimoxazole antibiotics. The prevalence rates of aer, traT, and PAI genes in the fecal isolates were 92%, 90.6%, and 46.6%, respectively.
Further, their prevalence rates in urine isolates were 96%, 97.3%, and 41.3%, in that order.
Conclusions: The presence of the high frequency of pathogenic islands (PAIs), especially in fecal samples, is important because
these genes are easily transmitted and convert a commensal bacterium into a pathogen. Because only the genome of pathogenic
bacteria has been unwrapped, little attention has been paid to PAIs in commensal bacteria.
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1. Background
Nosocomial infections constitute the major reason for
death among inpatients. These infections, which are often
acquired as a result of urinary tract infection (UTI), surgi-
cal wounds and lower respiratory tract infections, might
be endogenous or cross-infection (1). Urinary tract infec-
tions (pyelonephritis and cystitis) are considered to be the
second major hospital infections in humans (1, 2). Though
this infection is considered to be an easily curable disease,
an estimated 150 - 250 million patients of UTI are identified
yearly worldwide, accounting for > 7 million doctor office
visits in the United States (3). Moreover, 70% - 95% of the
UTI occurs by urinary pathogenicEscherichia coli (UPEC) (4).
The host’s fecal flora is the major usual quick origin of E. coli
infections (5, 6).
The E. coli virulence factors (VFs) consist of protectins
such as serum resistance (traT) (7), associated islands (PAIs)
(8) and Tir-containing protein of E. coli (tcpc) (9); iron up-
take such as aerobactin (aer); cytotoxic necrotizing factor 1
(cnf1) and hemolysin A (hlyA); adhesins such as type 1 fim-
briae (fimH), A fimbriae (afa), S fimbriae (sfa), and P fim-
briae (papG) (10, 11). Uropathogenic E. coli produces a num-
ber of VFs, which protect these strains in the face of very
effective host protection and make it possible for them
to colonize in the urinary tract (11). Uropathogenic E. coli
strains display a wide genomic variety, due to having par-
ticular VFs located on mobile genetic elements called PAIs,
that are common in the horizontal transition of VFs (12).
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Aer gene encodes Aerobactin (siderophore) and has newly
been recognized as a VF in UPEC (13, 14). Other VFs such as
serum resistance capacity, due to TraT protein (the exter-
nal membrane protein) encoded by traT genes, have signif-
icant roles in the progression of UTI (15).
The treatment of UTI caused by UPEC often needs an-
tibiotic therapy. However, currently, there has been an
increase in the rate of antibiotic-resistant E. coli strains,
and UTI are considered an important health concern (16,
17). The emergence of antimicrobial resistance, especially
extended-spectrum beta-lactamases (ESBLs) and mainly
multidrug-resistant (MDR) in UPEC strains rise the very im-
portant danger to worldwide public health (18, 19). There-
fore, it is necessary to determine the factors related to the
pathogenicity of bacteria in each region to control the in-
fection and help eradicate the pathogen. Also, examining
the antibiotic resistance pattern of bacteria in each region
will allow physicians to prevent the development of antibi-
otic resistance by selecting the appropriate antibiotic.
2. Objectives
This study aimed to explore antimicrobial susceptibil-
ity and identify aer, traT, and PAI genes in E. coli isolates col-
lected from fecal and UTI specimens and determine the re-
lationship between PAI, traT, and aer genes in both popu-
lations studied in a center in Iran by multiplex polymerase
chain reaction (PCR) assay.
3. Methods
3.1. Bacterial Isolates
Uropathogenic E. coli isolates (n = 75) and commensal
fecal without UTI and diarrhea (n = 75) were collected from
the patients of educational hospitals, Shahrekord Center,
Iran, 2017. A number of 75 E. coli isolates from the urine
of patients with UTI containing significant counts (≥ 105
CFU/mL) were included in this study. Escherichia coli iso-
lates were identified by Gram staining, culture on Eosin
methylene blue (EMB) agar, MacConkey agar, and Blood
agar (Merck Co., Germany), and biochemical tests (IMViC
tests).
3.2. Antimicrobial Susceptibility Testing
Antibiotic susceptibility patterns for 14 antibiotics
were interpreted according to the Clinical and Laboratory
Standards Institute (CLSI) protocols by the disk-diffusion
technique (20). The antibiotic susceptibility of the bacteria
was determined by the disc diffusion method (Kirby-Bauer
method) for 14 antibiotics. After incubation, the diameter
of the inhibition zone was measured and interpreted ac-
cording to the standard antibiogram. The following antibi-
otics (Mast, Co) were included in this study: ampicillin (100
mg), imipenem (10 mg), piperacillin (10 mg), amikacin
(30 mg), cotrimoxazole (25 mg), ciprofloxacin (5 mg), cef-
tazidime (30 mg), nitrofurantoin (300 mg), gentamicin (10
mg), ceftriaxone (30 mg), nalidixic acid (30 mg), cefalotin
(5 mg), cefepime (30 mg), and tazocin (30 mg). The E. coli
ATCC 25922 was used as the control strain.
3.3. DNA Extraction andMultiplex PCR
DNA extraction was done by the boiling method. To ex-
tract DNA from the isolates, they were first cultured on the
EMB medium. For boiling, 3 - 5 colonies were inoculated
into a microtube containing 1,000µL of Tris buffer. The mi-
crotubes were then placed on a hot plate for 15 minutes at
95°C. Next, they were centrifuged at 14,000 rpm for 10 min-
utes. Finally, the supernatant containing DNA was trans-
ferred to another microtube (21). The purity of the DNA was
measured by a NanoDrop™ spectrophotometer. DNA sam-
ples by an OD260/OD280 ratio of ≥ 1.8 were used for the
next phase of the study. Multiplex PCR was performed for
aer (22), traT, and PAI (23). The sequences of primers used
for this study are listed in Table 1. The multiplex PCR was
optimized according to the following experimental condi-
tions: initial denaturation at 95°C for five minutes, 35 cy-
cles of 94°C for 30 seconds, 56°C for 30 seconds, and 72°C
for 40 seconds, followed by a final extension step at 72°C
for five minutes and holding a one-time cycle at 4°C for 5
minutes. In this test, E. coli ATCC 700928 was the positive
control and 16S rRNA gene was the internal control (24).
Table 1. Primers Used in the Study
Gen Type Primers Sequences (5’ - 3’) Size
aer
F: TACCGGATTGTCATATGCAGACCGT
602
R: AATATCTTCCTCCAGTCCGGAGAAG
traT
F: GGTGTGGTGCGATGAGCACAG
290
R: CACGGTTCAGCCATCCCTGAG
PAI
F: GGACATCCTGTTACAGCGCGCA
930
R: TCGCCACCAATCACAGCCGAAC
16SrRNA
F: AGGCCTTCGGGTTGTAAAGT
420
R: ACCTCCAAGTCGACATCGTT
3.4. Statistical Analysis
The Statistical Package for Social Sciences (SPSS) was
used for data analysis. The significance level was set at 0.05.
Comparisons of proportions were tested using chi-square
or Fisher’s exact test (two-tailed), as appropriate.
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4. Results
In this study, 41.33% of the patients were male, while
58.67% were female. Among the UPEC isolates, the highest
antibiotic resistance was reported on cefazolin, ampicillin,
and cotrimoxazole antibiotics. Most isolates were suscepti-
ble to amikacin, imipenem, cefepime, tazocin, and nitrofu-
rantoin. The antibiotic resistance pattern for 14 antibiotics
on 75 UTI isolates is presented in Figure 1.
No antibiotic resistance to more than 10 antibiotics
was observed in this study (Table 2). Multidrug resistance
patterns were determined based on resistance to three or
more different classes of antibiotics. It was found to be
62.67%.
Table 2. The Frequency of Resistance to Antibiotics by the Number of Resistant An-
tibiotic
Antibiotics Abundance Frequency (%)
Sensitivity to all 6 8
Resistant to one 6 8
Resistant to two 9 12
Resistant to Three 8 10.66
Resistant to Four 12 16
Resistant to Five 4 5.33
Resistant to Six 4 5.33
Resistant to seven 10 13.33
Resistant to eight 7 9.33
Resistant to Nine 5 6.66
Resistant to ten 2 2.66
In this study, in spite of the abundance of the aer, traT,
and PAI genes studied in both UPEC isolates and commen-
sal fecal without UTI and diarrhea isolates populations
(Figure 2), there was no correlation between the genes in
the two populations based on P values (P > 0.05) (Table 3).
The frequencies of aer gene in the E. coli isolated from
urine and fecal samples were 96% (n = 72) and 92% (n = 69),
respectively. Also, the total frequency of this gene was 94%
(n = 141). The frequencies of traT gene in the E. coli isolated
from urine and fecal samples respectively were 97.3% (n =
73) and 89.3% (n = 67), and totally it was 93.3% (n = 140).
Furthermore, the frequencies of PAI gene in the E. coli iso-
lated from urine and fecal samples were 41.33% (n = 31) and
46.67% (n = 35) in that order. The total frequency of PAI gene
in both groups it was 44% (n = 66) (Tables 4 and 5).
Regarding the study of genes in the E. coli isolated from
urine of patients with UTI and feces from healthy indi-
viduals, despite the high frequency of PAI, traT, and aer
genes, it cannot be concluded that the relationship be-
tween genes is the same as in both groups, according to
the tables. The high frequency of these genes can be at-
tributed to the bacteria’s need for these genes for growth
and combined with some other virulence factors to cause
UTI. The electrophoresis technique was performed on the
polyacrylamide gel after completing the PCR steps. After
electrophoresis, the polyacrylamide gel was stained with
silver nitrate method (Figure 3).
5. Discussion
Escherichia coli resistance to antimicrobial agents is re-
ported all over the world, and the speed of increased re-
sistance has caused concerns about resistance to antibi-
otics (25). According to the results of this study, the best-
recommended antibiotics in cases requiring urgent treat-
ment are amikacin and imipenem, and in subsequent
lines, the use of cefipime and nitrofurantoin is suggested.
Owing to high resistance to ceftriaxone (45.3%) and cef-
tazidime (56%), and because resistance genes to broad-
spectrum cephalosporins are mainly transmitted through
plasmids among bacteria, they can spread among other
bacteria (26). Imipenem resistance was 5.3%. Imipenem is
a broad-spectrum antibiotic and is stable opposite to most
β-lactamases. Imipenem resistance, which is intentionally
caused by hydrolyzing enzymes such as carbapenemases,
is increasing in Gram-negative bacteria, especially Enter-
obacteriaceae (27). Therefore, it shows a serious risk that
requires more care and further investigation for the pres-
ence of carbapenemase enzymes.
In a study on 52 patients with UTI caused by E. coli,
Heidari-Soureshjani et al., found 85.71% resistance to ampi-
cillin, 78.78% to nalidixic acid, and 46.51% to ciprofloxacin.
The highest degree of susceptibility was observed in nitro-
furantoin, amikacin, and gentamicin; this result is consis-
tent with that of our study (28). In Shokri et al. research
conducted in Isfahan, Imipenem resistance inE. coli strains
was found to be 4%, which is quite consistent with the re-
sults of our study. However, resistance to tazocin was re-
ported to be 10%, which is much higher than 1.3% observed
in our report (29). In another study, Rahimi et al. exam-
ined 194 bacterial susceptibility patterns of UTI caused by
E. coli. The resistance rates to ciprofloxacin, ceftazidime, ni-
trofurantoin, gentamicin, ampicillin, cotrimoxazole, cef-
triaxone and nalidixic acid were 1% and 31%, 4%, 28%, 72%,
70%, 32%, and 73%, respectively.
The results are consistent with those of our study with
respect to resistance rates of nitrofurantoin, ampicillin,
cotrimoxazole, and ceftriaxone (30). In another study car-
ried out in Tehran between 2011 - 2012, 281 cases of E. coli
showed the highest rates of resistance to cotrimoxazole,
nalidixic acid, and cefazolin, with the highest suscepti-
bility being observed in imipenem, nitrofurantoin, and
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Figure 1. Antimicrobial resistance pattern for 75 UTI isolates
Table 3. Distribution of aer, traT, and PAI Genes in Both Studied Populations
Gene Uropathogenic Commensal Total P Value
Aer 96 92 94 0.494
traT 97.3 89.3 93.3 0.05
PAI 41.3 46.7 44 0.511
Table 4. Virulence Pattern Detected Among Escherichia coli Strains in Both Studied Populations
Number Only PAI Only traT Only Aer traT, PAI aer, PAI Aer, traT traT, PAI, Aer
UTI 0 1 1 2 1 42 28
Stool 1 3 5 2 2 32 30
Sum 1 4 6 4 3 74 58
Table 5. Relationship Between PAI, traT, and aer Genes in Both Populations Studied
Aer traT PAI
No Yes P Value No Yes P Value No Yes P Value
UTI 72 3
0.494
73 2
0.05
31 44
0.511
Stool 69 6 67 8 35 40
piperacillin. Resistance rates to cefazolin and cotrimox-
azole and the susceptibility to ampicillin and nitrofuran-
toin are consistent with our reports (31). In another study
performed in India in 2017, 351 urine specimens were re-
ported with 43% MDR and the highest antibiotic suscep-
tibility was found in imipenem, nitrofurantoin, amikacin,
tazocin and gentamicin, respectively. The strongest resis-
tance to ampicillin, cefuroxime, ceftriaxone (66.58%), and
ciprofloxacin (82.85%) was reported, which confirms the
results of our study (32). One of the significant points
4 Jundishapur J Microbiol. 2020; 13(6):e98683.
Rezaei MH et al.
0
10
20
30
40
50
60
70
80
aer traT PAI
UTI
Stool
Figure 2. Distribution of aer, traT, and PAI genes in both studied populations
of this study and its comparison with previous studies
is that, in antibiotics such as gentamicin, nitrofurantoin,
amikacin, and imipenem, the rate of resistance increases
with a slower pace compared to other antibiotics such as
ampicillin and cotrimoxazole.
In another phase of the current study (Table 2),
we examined MDR, Extensive Drug-Resistant (XDR), and
Pandrug-Resistant (PDR). Based on MDR pattern provided
by Centers for Disease Control and Prevention (CDC) im-
plementation for different antibiotic groups, 16 (21.3%) iso-
lates were MDR and 31 (41.3%) isolates were XDR. According
to the definition of CDC, XDR strains were also MDR. There-
fore, a total of 47 strains (62.6%) were MDR. Interestingly,
although no PDR was observed, the abundance of XDR in
the ratio of MDR can be considered a serious alarm, which
does not have a good prospect due to the increase in resis-
tance, and causes a serious risk. In a study conducted by
Shokri et al. in 2015 in Isfahan, MDR was found to be 79%,
which is consistent with our results (25, 29).
In this study, the frequency of aer and traT genes was
high in both studied populations. Our results showed
that 94% of the isolates had aer gene and 93.3% of them
had traT gene in both populations. Also, their frequency
was higher in the population with UTI. The results of our
study on the frequency of PAI shows that its frequency is
lower than that of the aer and traT genes and it is 44% in
both populations, which is significant. Contrary to the two
other genes, the amount of PAI gene in the healthy popu-
lation is slightly higher than that of UTI. The high preva-
lence of these genes reflects the role of host environment
in the acquisition and transfer of virulence genes in the
bacteria and consequently, the induction of pathogenicity
to non-pathogenic bacteria and its transformation into a
pathogenic bacterium. In our study, although the preva-
lence of the three genes studied in both populations was
high, there was no correlation between the statistical fre-
quencies of each gene in the two studied groups (P > 0.05).
A research in a center in Iran (Kashan) by Neamati et
al. indicated that the frequency rates of aer, PAI, and traT
genes in 370 E. coliurine samples were 61.4%, 30.7%, and 74%,
respectively, which are lower than the frequency observed
in the urine samples of our study (33). Additionally, in a
survey of 104 E. coli isolates of UTI by Sholibor, in 2016 in
eastern Iran (Zabol), frequencies of traT (38%) and PAI (57%)
were reported, which is different from the current study
(34). Also, the study of Navidinia et al. was conducted in
Tehran in 2013 on 100 isolates of E. coli from UTI (n = 50) and
stool of children (n = 50) who were 2 - 12 years old and had
no infection. The prevalence of PAI gene was 89% and 38%
in the urine and stool, respectively, and their frequency is
different from that of our study. This may be due to the dif-
ference in geographical area and the small number of sam-
ples for comparison or the target group, i.e. children (35).
In a report by Samei et al. on 150 E. coli strains of UTI
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Figure 3. Column 1: Ladder 100 bp, column 2: negative control, column 3: PAI posi-
tive control and internal control (16SrRNA), columns 4 and 5: samples have PAI gene
and 16SrRNA, column 6: aer positive control and internal control, columns 7 and
8 of the samples have aer and 16SrRNA, column 9 positive control of traT 16SrRNA,
columns 10 and 11 samples have traT and 16SrRNA.
and 50 strains of stools, the frequency of PAI gene was 98.7%
in UTI and 88% in fecal samples (96% in total). Interest-
ingly, MDR was reported at 92.7%, and all MDR patients had
PAI gene (36). In a study by Moreno et al. carried out in
Barcelona in 2008, there were 109 isolates of E. coli con-
taining 42 isolates of UTI and 67 isolated from fecal sam-
ples. The frequencies of traT gene in UTI and fecal were
57% and 42%, respectively (37). In a study performed in
Brazil by Oliveira et al. in 2011 on 204 E. coli isolated from
UTI, the abundance of aer, PAI, and traT genes was reported
32, 41, and 76%, respectively (38). Moreover, Hassan et al.
(2017) carried out a research in Sudan on 150 isolates of
E. coli containing 100 isolates of UTI and 50 fecal isolates,
demonstrating that the frequencies of aer gene in the iso-
lates from UTI and fecal isolates were 16% and 92%, respec-
tively (39).
Considering the frequency of aer gene in fecal speci-
mens that provides iron absorption for the metabolism of
the bacteria in the intestinal environment, the idea that
the intestinal environment is a reservoir for pathogen bac-
teria is augmented (40). TraT is a bacterial gene that is lo-
cated on the outer membrane and is a common gene of
Salmonella, Shigella, E. coli, and Enterobacter. It prevents the
impact of complements on the bacteria. Considering its
prevalence in most studies on uropathogenic E. coli, this
gene can be an interesting suggestive target for therapeu-
tic interventions, an issue that requires further investiga-
tion. The presence of the high frequency of PAIs, espe-
cially in fecal samples, is important because these genes
are easily transmitted and convert a commensal bacteria
into a pathogen. Owing to the fact that only the genome
of pathogenic bacteria has been noted, little attention has
been paid to PAIs in commensal bacteria. Therefore, it
is recommended that the subtypes of these PAIs should
be explored to gain a better understanding of the com-
mensal strains as a potential pathogenic source. Some of
the strains studied in both populations were of the same
pattern for the presence of these virulence genes. One
of the reasons for this can be the variation of flora E. coli
and uropathogenic or the genetic exchange of DNA be-
tween strains, which requires further investigation. On the
other hand, it is necessary to pay more attention to these
pathogenic genes for the purpose of treatment and ther-
apy due to the increasing trend of these genes in the re-
ports compared to previous years.
5.1. Conclusion
Higher degree of the presence of aer and traT viru-
lence factors in strains isolated from urine can indicate
the higher potential of UPEC strains compared with fecal
strains. High-frequency PAIs genes in E. coli commensal
isolates compared with UPEC isolates is important because
these genes are easily transmitted and convert some com-
mensal bacteria into a pathogen. This study indicated that
ampicillin, cefazolin, and cotrimoxazole should be reeval-
uated for the treatment of UTI caused by E. coli. In emer-
gency cases, antibiotics such as amikacin, imipenem, and
tazocin were used in this area. The study also showed the
high rates of XDR and MDR strains among patients, reveal-
ing an urgent need to revise the pattern of antibiotic use.
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